RESUMO
PURPOSE: We investigated respiratory muscle strength, diaphragm mobility, lung function, functional capacity, quality of life, body composition, breathing pattern, and chest wall (VT,CW) and compartmental volumes of Mucopolysaccharidosis (MPS) patients and compared these variables with matched healthy individuals. METHODS: A cross-sectional study with data analyzed separately according to age group. A total of 68 individuals (34 MPS and 34 matched-healthy subjects) were included. Six-minute walking test assessed functional capacity and ultrasound assessed diaphragm mobility during quiet spontaneous breathing (QB). Optoelectronic plethysmography assessed VT,CW and breathing pattern during QB in two different positions: seated and supine (45° trunk inclination). RESULTS: Body composition, lung function, respiratory muscle strength, and functional capacity were reduced in MPS (all p < 0.01). Diaphragm mobility was only reduced in adolescents (p = 0.01) and correlated with body composition and breathing pattern. Upper chest wall compartmental volumes were significantly lower in MPS, while abdominal volume only differed significantly in adolescents. Percentage contribution (%) of upper ribcage compartments to tidal volume was reduced in MPS children, whereas %AB was significantly increased compared with healthy subjects. CONCLUSION: Lung function, respiratory muscle strength, functional capacity, diaphragm mobility, and quality of life are reduced in MPS compared with matched healthy subjects. VT,CW was mainly reduced due to pulmonary and abdominal ribcage impairment. Implications for RehabilitationReduction in respiratory muscle strength, functional capacity, diaphragm excursion and low lung volumes were found in individuals with Mucopolysaccharidoses (MPS).Chest wall volumes and the upper chest wall compartmental volumes during quiet spontaneous breathing are reduced in MPS.Assessment and monitoring of the respiratory system for individuals with MPS should be performed periodically through standardized assessments to enable identification of changes and early intervention by rehabilitation protocols.This study may provide the necessary basis for carrying out respiratoty rehabilitation protocols that can improving chest wall mechanics with breathing exercise in this group.
Assuntos
Parede Torácica , Criança , Humanos , Adolescente , Parede Torácica/diagnóstico por imagem , Diafragma/diagnóstico por imagem , Qualidade de Vida , Estudos Transversais , Respiração , Músculos RespiratóriosRESUMO
INTRODUCTION: There is scarce information about middle-term evolution of hospitalized patients who suffer from pneumonia caused by COVID-19. The objective of this study is to determine the clinical, respiratory, tomographic and functional impact on COVID-19 patients with moderate (MP) to severe (SP) pneumonia after six months of acute infection. METHODS: Analysis was carried out by MP and SP groups, desaturators during the 6-minute-walking test and the presence of fibrotic like pattern on HRCT. Outcomes at 3 and 6 months were compared. RESULTS: The analysis included 129 patients, between 57 ± 11 years old. Frequent comorbidities were: arterial hypertension 38.1%, diabetes 30.4%, respiratory 18.6%). Comparing 3 and 6 months, improvement in quality of life was observed in MP and SP. The DP walked less meters in the MWT, worsened life quality and more fibrotic like pattern. The fibrotic pattern was related to the fall of CVF < 80% on MP and SP (p = 0.048 and p = 0.007), and with DP (p = 0.002). On multivariated analysis, the fibrotic like pattern was associated to the reduction of CVF with OR = 4.44 (1.94-10.18, p <0.01) and desaturation OR = 5.01(1.63-15.42, p < 0.01). On this cohort it was observed more functional and tomographic compromise on the DP The fibrotic like pattern was related to worse functional evolution and oximetry. DISCUSSION: Follow-up after discharge of COVID-19 patients with SP, DP or fibrotic changes in HCRT is underlined.
Introducción: Hay información escasa sobre la evolución de los enfermos hospitalizados por neumonía por COVID-19 a mediano plazo. El objetivo de este estudio fue determinar en pacientes con neumonía moderada (NM) o grave (NG) por COVID-19, el impacto clínico, funcional respiratorio y tomográfico a los 6 meses. Métodos: Se realizó análisis según grupos de NM y NG, desaturadores (PD) en la prueba de caminata de 6 minutos y presencia del patrón tomográfico de alta resolución (TACAR) símil fibrótico. Se compararon los resultados a los 3 y 6 meses. Resultados: Se incluyeron 129 pacientes, edad 57 ± 11 años, comorbilidades frecuentes (hipertensión arterial 38.1%, diabetes 30.4% y respiratorias 18.6%). Al comparar 3 y 6 meses se observó mejoría de la calidad de vida en NM y NG. Los PD presentaron menor metraje caminado, peor calidad de vida y mayor presencia de patrón símil fibrótico. Este patrón se relacionó con la caída de la FVC 80% en NM y NG (p = 0.048 y p = 0.007), y con PD (p = 0.002). En el análisis multivariado, el patrón símil fibrótico s e asoció a la reducción de la CVF con OR = 4.44 (1.94-10.18, p <0.01) y a la desaturación, OR = 5.01 (1.63-15.42, p <0.01). En esta cohorte se observó mayor compromiso funcional y tomográfico en los PD. El patrón símil fibrótico se relacionó con peor evolución funcional y oximétrica. Discusión: Es importante el seguimiento de los pacientes con NG, los PD y los que presentan patrón fibrótico al alta de neumonía por COVID-19.
Assuntos
COVID-19 , Idoso , Hospitalização , Humanos , Pessoa de Meia-Idade , Qualidade de Vida , Tomografia Computadorizada por Raios X , CaminhadaRESUMO
Resumen Introducción: Hay información escasa sobre la evolución de los enfermos hospitalizados por neumonía por COVID-19 a mediano plazo. El objetivo de este estudio fue determinar en pacientes con neumonía moderada (NM) o grave (NG) por COVID-19, el impacto clínico, funcional respiratorio y tomográfico a los 6 meses. Métodos: Se realizó análisis según grupos de NM y NG, desaturadores (PD) en la prueba de cami nata de 6 minutos y presencia del patrón tomográfico de alta resolución (TACAR) símil fibrótico. Se compararon los resultados a los 3 y 6 meses. Resultados: Se incluyeron 129 pacientes, edad 57±11 años, comorbilidades frecuentes (hipertensión arterial 38.1%, diabetes 30.4% y respiratorias 18.6%). Al comparar 3 y 6 meses se ob servó mejoría de la calidad de vida en NM y NG. Los PD presentaron menor metraje caminado, peor calidad de vida y mayor presencia de patrón símil fibrótico. Este patrón se relacionó con la caída de la FVC 80% en NM y NG (p = 0.048 y p = 0.007), y con PD (p = 0.002). En el análisis multivariado, el patrón símil fibrótico s e asoció a la reducción de la CVF con OR = 4.44 (1.94-10.18, p<0.01) y a la desaturación, OR = 5.01 (1.63-15.42, p<0.01). En esta cohorte se observó mayor compromiso funcional y tomográfico en los PD. El patrón símil fibrótico se relacionó con peor evolución funcional y oximétrica. Discusión: Es importante el seguimiento de los pacientes con NG, los PD y los que presentan patrón fibrótico al alta de neumonía por COVID-19.
Abstract Introduction: There is scarce information about middle-term evolution of hospitalized patients who suffer from pneumonia caused by COVID-19. The objective of this study is to determine the clinical, respiratory, tomographic and functional impact on COVID-19 patients with moderate (MP) to severe (SP) pneumonia after six months of acute infection. Methods: Analysis was carried out by MP and SP groups, desaturators during the 6-minute-walking test and the presence of fibrotic like pattern on HRCT. Outcomes at 3 and 6 months were compared. Results: The analysis included 129 patients, between 57 ± 11 years old. Frequent comorbidities were: arterial hypertension 38.1%, diabetes 30.4%, respiratory 18.6%). Comparing 3 and 6 months, improvement in quality of life was observed in MP and SP. The DP walked less meters in the MWT, worsened life quality and more fibrotic like pattern. The fibrotic pattern was related to the fall of CVF < 80% on MP and SP (p = 0.048 and p = 0.007), and with DP (p = 0.002). On multivariated analysis, the fibrotic like pattern was associated to the reduction of CVF with OR = 4.44 (1.94-10.18, p<0.01) and desaturation OR = 5.01(1.63-15.42, p < 0.01). On this cohort it was observed more functional and tomographic compromise on the DP The fibrotic like pattern was related to worse functional evolution and oximetry. Discussion: Follow-up after discharge of COVID-19 patients with SP, DP or fibrotic changes in HCRT is underlined.
RESUMO
Use of the six-minute walk test has been proposed as a prognostic marker in liver cirrhosis. In the Letter to the Editor presented here, the authors highlight some important points, which were raised after the article was published in the November issue of the World Journal of Hepatology.
RESUMO
Background: Congenital heart disease (CHD) entails structural defects in the morphogenesis of the heart or its main vessels. Analyzing exercise capacity of children and adolescents with CHD is important to improve their functional condition and quality of life, since it can allow timely intervention on poor prognostic factors associated with higher risk of morbidity and mortality. Objective: To describe exercise capacity in children and adolescents with CHD compared with healthy controls. Methods: A systematic review was carried out. Randomized clinical trials and observational studies were included assessing exercise capacity through direct and indirect methods in children and adolescents between 5 and 17 years-old. A sensitive analysis was performed including studies with CHD repaired participants. Additionally, it was sub-analyzed by age range (< and ≥ 12 years old). Two independent reviewers analyzed the studies, extracted the data, and assessed the quality of the evidence. Results: 5619 articles were found and 21 were considered for the review. Eighteen articles used the direct exercise capacity measurement method by cardiopulmonary exercise test (CPET). The CHD group showed significant differences in peak oxygen consumption (VO2peak) with a value of -7.9 ml/Kg/min (95% CI: -9.9, -5.9, p = 0.00001), maximum workload (Wmax) -41.5 (95% CI: -57.9, -25.1 watts, p = 0.00001), ventilatory equivalent (VE/VCO2 ) slope 2.6 (95% CI: 0.3, 4.8), oxygen pulse (O2 pulse)-2.4 ml/beat (95% CI: -3.7, -1.1, p = 0.0003), and maximum heart rate (HRmax) -15 bpm (95% CI: -18, -12 bpm, p = 0.00001), compared with healthy controls. Adolescents (≥ 12 yrs) with CHD had a greater reduction in VO2peak (-10.0 ml/Kg/min (95% CI: -12.0, -5.3), p < 0.00001), Wmax (-45.5 watts (95% CI: -54.4, -36.7), p < 0.00001) and HRmax (-21 bpm (95% CI: -28, -14), p<0.00001). Conclusion: Suffering CHD in childhood and adolescence is associated with lower exercise capacity as shown by worse VO2peak, Wmax, VE/VCO2 slope, O2 pulse, and HRmax compared with matched healthy controls. The reduction in exercise capacity was greater in adolescents. Systematic Review Registration: www.crd.york.ac.uk/prospero/display_record.php?RecordID=208963, identifier: CRD42020208963.
RESUMO
BACKGROUND: Patients with cirrhosis are at risk of cirrhotic cardiomyopathy, with resulting cardiac dysfunction and exercise limitations. Six minute walking test (6MWT) assesses functional status and predicts morbidity and mortality in cardiopulmonary diseases. AIM: To determine if it associates with mortality by analyzing 6MWT performance in patients with liver cirrhosis. METHODS: A cohort of 106 cirrhotic patients was evaluated in the outpatient setting with echocardiogram and 6MWT and follow up for one year to document hepatic decompensation and mortality. The distance in meters was recorded at the end of 6 min (6MWD). RESULTS: This cohort had a mean age of 51 years and 56% male; patients were staged as Child A in 21.7%, B 66% and C 12.3%. Walk distance inversely correlated with Child scores, and was significantly reduced as Child stages progresses. Patients who died (10.4%) showed shorter mean 6MWD (P = 0.006). Low 6MWD was an independent predictor of mortality (P = 0.01). CONCLUSION: 6MWT is a noninvasive inexpensive test whose result is related to Child scores and mortality. It is useful to identify patients with liver cirrhosis at high risk of mortality for closer monitoring and potential early intervention.
RESUMO
Introduction: The efficacy of long-acting bronchodilators for COPD associated with biomass (BE-COPD) has not been properly evaluated. Objective: To determine the acute effect of indacaterol (IND) 150 µg q.d and tiotropium (TIO) 18 µg q.d. on lung hyperinflation, walking distance (WD) and dyspnea during the six-minute walking test (6MWT) in moderate BE-COPD at 30, 60 and 240 mins post-drug administration. Design: Randomized, controlled, open-level, crossover noninferiority clinical trial. Forty-two women with BE-COPD were randomly assigned to a bronchodilator sequence: IND-TIO or vice versa. Results: There were statistically significant changes over time in inspiratory capacity (IC) (p<0.0001), FEV1 (p<0.0001) and FVC (p<0.0001) when IND was used. When TIO was administered, an increase over all time periods was observed only for FEV1 (p<0.0001) and FVC (p<0.0001), whereas for IC an increase was observed only at 30 mins and 24 hrs after TIO administration. We did not find clinically significant increases in WD and dyspnea after the administration of both bronchodilators. Conclusion: Both IND and TIO showed significant and fast onset improvement in hyperinflation. Therefore, either of them may be recommended as a first line of treatment for COPD associated with BE-COPD.
Assuntos
Biomassa , Exposição Ambiental/efeitos adversos , Indanos/administração & dosagem , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Quinolonas/administração & dosagem , Fumaça/efeitos adversos , Brometo de Tiotrópio/administração & dosagem , Administração por Inalação , Idoso , Idoso de 80 Anos ou mais , Broncodilatadores/administração & dosagem , Estudos Cross-Over , Teste de Esforço , Feminino , Volume Expiratório Forçado/efeitos dos fármacos , Humanos , Capacidade Inspiratória/efeitos dos fármacos , Pessoa de Meia-Idade , Doença Pulmonar Obstrutiva Crônica/etiologia , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Espirometria , Resultado do Tratamento , Capacidade Vital/efeitos dos fármacosRESUMO
O objetivo do estudo foi estratificar os fatores de risco cardiovasculares (FR) e avaliar os efeitos de um programa de exercício físico (PEF) por três meses em pacientes diagnosticados com doença arterial obstrutiva periférica (DAOP) através do teste de caminhada de 6 minutos (TC6), utilizando como parâmetro a distância total percorrida (DTP), tempo inicial da dor (TID), tempo final da dor (TFD) e tempo total da dor (TTD). O estudo foi composto por 12 voluntários, encaminhados para o programa de Reabilitação Física. Para estratificar os FR houve aplicação de questionário contendo pergunta objetivas com opção de sim ou não sobre tabagismo, diabetes mellitus, etilismo, hipertensão arterial, sedentarismo, hereditariedade, dislipidemia e obesidade, adotou-se o índice de massa corpórea. O TC6 foi realizado em um corredor de 22 metros e o paciente foi orientado a informar aos avaliadores o momento de início da dor (TID) e somente parar quando a dor tornar-se insuportável para continuar a caminhada. O TFD foi estabelecido quando o paciente retornou ao TC6. Ao final do teste foi calculada a DTP que o paciente atingiu. O teste de ANOVA foi utilizado para comparar as condições pré e pós-reabilitação, tendo nível de significância quando p<0,05. Observou-se que todos os pacientes mostraram-se sedentários, 58,3% são dislipidêmicos, 50% são tabagistas, hipertensos e apresentam hereditariedade. Houve diferença significativa na DTP (327,7±83,3 vs 431,7±90,5), TID (01:52±0:36 vs 02:59±0:41) e TTD (01:55±0:14 vs 00:45±0:36) pré e pós-reabilitação. O PEF para pacientes com DAOP se mostrou eficaz na DTP, TID, TTD.
RESUMO
Introducción y objetivos: La enfermedad cardiovascular constituye la primera causa de muerte y de gastos sanitarios debido a sus consecuencias. En prevención secundaria, los programas de rehabilitación cardiaca mejoran el estado funcional y la calidad de vida, e incrementan la supervivencia. Métodos y materiales: Estudio observacional, descriptivo y prospectivo, en el que se incluyeron 31 pacientes (19 hombres y 14 mujeres), con edad promedio de 64 ± 11 años. El test de caminata de 6 minutos sirvió para estimar el consumo de oxígeno máximo indirecto (VO2máx). Se midió la frecuencia cardiaca y se estimó el doble producto como indicadores hemodinámicos. Las pruebas se realizaron antes y después de 12 sesiones de entrenamiento entre el 50 y 70% de la frecuencia cardiaca máxima, 60 min, 3 veces por semana, durante un mes. Resultados: Luego de la intervención, se observaron mayores valores en el VO2 (9,6 ± 2 mL/kg-1/min-1 vs. 11,09 ± 1,9 mL/kg-1/min-1; p = 0,002) y en la distancia alcanzada en el test (244,5 ± 80,1 m vs. 303,2 ± 78,1 m; p = 0,002). No hubo diferencias en los indicadores hemodinámicos (p > 0,05). Conclusiones: El programa de rehabilitación cardiaca reportó una mejoría de tolerancia al ejercicio para los pacientes posquirúrgicos cardiovasculares en promedio del 14%, sin modificar la función hemodinámica.
Introduction and objectives:Cardiovascular disease is the leading cause of death and medical expenses due to its consequences. In secondary prevention, cardiac rehabilitation programs improve functional status, quality of life and overall survival. Methods and materials: An observational, descriptive and prospective study was performed. Thirty one subjects (19 male, 14 female), mean age 64 ± 11 years. The 6-minute walk test served to estimate the indirect maximal oxygen consumption (VO2max). We measured the heart rate and double product was estimated as hemodynamic indicators. The tests were performed before and after 12 training sessions at between 50 and 70% of maximum heart rate, for 60 min, 3 times a week, during one month. Results: After the intervention we observed higher values of VO2 (9.6 ± 2.0 mL.kg-1.min-1 vs. 11.09 ± 1.9 mL.kg-1.min-1; p = 0.002) and a longer distance achieved in the walking test (244.5 ± 80.1 m vs. 303.2 ± 78.1 m; P = .002). There were no differences in hemodynamic indicators (P > .05). Conclusions: Cardiac rehabilitation program reported an improvement in exercise tolerance in post-surgical cardiovascular patients in a 14% of the cases. It did not show a variation in hemodynamic function.
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Doenças Cardiovasculares , Reabilitação Cardíaca , Terapia por Exercício , Teste de CaminhadaRESUMO
Introduction: Post-infectious bronchiolitis obliterans (BO) is a chronic respiratory disease that is established as a consequence of a lung infection produced by adenovirus. The clinical and radiological evidence as well as spirometric variables are the cornerstones of diagnosis; however, the functional impact of lung damage, assessed through the six minute walking test (6MWT), has been scarcely studied in this group of patients, notwithstanding it has been recommended in the Chilean guidelines. The aim of the study is to evaluate the correlation between spirometric variables and 6MWT performance in patients diagnosed with BO. Patients and Methods: Correlation study conducted in pediatric pulmonary rehabilitation program of Guillermo Grant Benavente Hospital from Concepción. Chile. Records of spirometry (FEV1, FVC, FEV1/FVC and FEF25-75) and 6MWT(Distance walked (DW), heart rate, oxygen saturation, dyspnea and leg fatigue) of 22 children and adolescents diagnosed with BO were selected. The absolute values of spirometric and 6MWT variables were compared with reference values of Knudson et al and Gatica et al respectively. Results are expressed by median and range (maximum and minimum). In the statistical analysis, normality test (Kolmogorov-Smirnov), non-parametric test (Wilcoxon, Mann-Whitney) and correlation analysis (Rho-Spearman) were done by SPSS 11.5 with significance of p < 0.05. Results: The spirometry was obstructive in all patients, advanced ventilatory limitation was found in 9 children, moderate in 4, mild in 3 and minimum in 6. The WD was 597 m (750-398), 9% below the predicted value according to age (p < 0.003). The WD was lower in those with greater severity in spirometric impairment (p = 0.012). The WD expressed as a percentage of predicted value showed a significant correlation with % FEV1 (r = 0.70, p = 0.0001), FEV1/FVC ratio (r = 0.58, p = 0.004) and FEF25-75% (r = 0.70, p = 0.0001). On the other hand only saturation at the end of 6MWT showed significant correlation with % FVC (r = 0.44, p = 0.04). Conclusion: Performance during the 6MWT was positively correlated with spirometry, validating the 6MWT as a tool to assess the functional impact of lung damage in patients with BO. Future prospective studies are needed to evaluate the correlation between lung function and exercise tolerance in these patients.
Introducción: La bronquiolitis obliterante (BO) post infecciosa es una enfermedad respiratoria crónica que se establece como secuela de una infección pulmonar principalmente por adenovirus. La evidencia clínica, espirométrica y radiológica son los pilares del diagnóstico, sin embargo, pese a estar sugerido en las actuales guías nacionales, la repercusión funcional del daño pulmonar a través del test de caminata de seis minutos (C6M) ha sido escasamente estudiado en este grupo de pacientes. El objetivo de este estudio es evaluar la correlación entre variables espirométricas y resultado del C6M en una muestra de pacientes con BO. Pacientes y Métodos: Estudio correlacional donde fueron seleccionados los registros de espirometría (VEF1, CVF, VEF1/CVF y FEF25-75) y de C6M (Distancia caminada (DC), frecuencia cardíaca, saturación de oxígeno, disnea y fatiga de piernas) de 22 niños y adolescentes con diagnóstico de BO ingresados al programa de rehabilitación respiratoria infantil del Hospital Dr. Guillermo Grant Benavente de Concepción. Los valores absolutos de las variables espirométricas y C6M se compararon con valores predichos de Knudson y Gatica respectivamente. En el análisis estadístico se realizaron pruebas de normalidad (Kolmogorov-Smirnov), de contraste (Wilcoxon y Mann-Whitney) y análisis de correlación (Rho-Spearman). Los resultados se expresan en mediana, rango máximo y mínimo. Se consideró significativo p < 0,05. Resultados: En la espirometría se encontró alteración ventilatoria obstructiva de grado avanzado en 9, moderada en 4, leve en 6 y mínima en 3 niños. La DC fue de 597 m (750-398), 9% por debajo del valor predicho para la edad (p < 0,003). La DC fue menor en aquellos con mayor grado severidad en la alteración espirométrica (p = 0,012). La DC expresada en porcentaje del valor predicho mostró una correlación significativa con % VEF1 (r = 0,70;p = 0,0001), índice VEF1/CVF (r = 0,58;p = 0,004) y % FEF25-75 (r = 0,70;p = 0,0001). Sólo la saturación al final del C6M se correlacionó significativamente con % CVF (r = 0,44; p = 0,04). Conclusión: El rendimiento durante el C6Mse correlacionó con espirometría, validando al C6M como herramienta para valorar la repercusión funcional del daño pulmonar en pacientes con BO. Futuros estudios son necesarios para confirmar esta correlación.
Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Espirometria , Bronquiolite Obliterante/etiologia , Bronquiolite Obliterante/fisiopatologia , Caminhada/fisiologia , Consumo de Oxigênio/fisiologia , Testes de Função Respiratória/métodos , Infecções Respiratórias/complicações , Capacidade Vital/fisiologia , Volume Expiratório Forçado/fisiologia , Frequência Cardíaca/fisiologia , Pulmão/fisiopatologiaRESUMO
INTRODUÇÃO: A atividade física é uma das formas de prevenção ao aparecimento de fatores de risco cardiovascular, como a hipertensão arterial sistêmica (HAS) e o diabetes mellitus (DM). Uma das formas de avaliar é o teste de caminhada de seis minutos (TC6), que é um teste submáximo, simples de ser realizado, de baixo custo e alta reprodutibilidade. OBJETIVOS: Comparar o desempenho funcional de mulheres portadoras de risco cardiovascular, por meio do TC6. MÉTODOS: 45 mulheres foram alocadas em três grupos: G1 (com diagnóstico de HAS DM), G2 (diagnóstico de HAS) e G3 (voluntárias saudáveis). Inicialmente, as voluntárias realizaram o TC6 com caráter de aprendizado e uma hora depois o teste com caráter avaliativo. Considerou-se como variáveis pré e pós-teste a saturação periférica de oxigênio, a frequência cardíaca, a pressão arterial, a glicose e a distância percorrida. A análise estatística foi realizada com significância estipulada de p < 0,05. RESULTADOS: Todos os grupos aumentaram significativamente a distância percorrida no teste avaliativo, e tiveram acréscimo na pressão arterial e redução do índice glicêmico. CONSIDERAÇÕES FINAIS: O TC6 pode ser utilizado para avaliação da capacidade funcional de mulheres portadoras de HAS e DM como fatores de risco cardiovascular, demonstrando-se seguro e submáximo.
INTRODUCTION: The practice of physical activities is one of the options used for cardiovascular risks prevention, such as systemic arterial hypertension (SAH) and diabetes mellitus (DM). One of the ways to make an evaluation of it is the 6-minute-walk test (6MWT), which is a submaximal test, simple to be done, of low cost and high productive. OBJECTIVES: To compare the functional acting of women's organism with cardiovascular risk, through the 6MWT. METHODS: 45 women were allocated in 3 groups: G1 (with SAH DM diagnostic), G2 (SAH diagnostic) and G3 (healthy volunteers). Initially the volunteers made the 6MWT for learning and one hour later for evaluation. Saturation of peripheral oxygen, cardiac frequency, arterial blood pressure, glucose and distance made were considered as pre- and post-tests. The statistic analysis was made with stipulated relevance of p < 0,05. RESULTS: All groups that increased the distance made during the evaluation test, had higher blood pressure and reduction of the glucose indication. CONCLUSIONS: 6MWT can be used for evaluation of the functional acting of women's organism with SAH and DM as cardiovascular risk factors, being safe and submaximal.
Assuntos
Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Diabetes Mellitus , Tolerância ao Exercício , Fatores de Risco , CaminhadaRESUMO
Existen pocos estudios sobre el efecto de la Ventilación de doble nivel de presión positiva (VNI) sobre el ejercicio en pacientes con EPOC. El objetivo fue evaluar el impacto de la VNI en la respuesta a ejercicios máximos ysubmáximos en pruebas de campo en pacientes con EPOC. Fueron incluidos pacientes con EPOC (definición GOLD). Se les realizó una prueba de 6 minutos (según normativas de ATS), de escalera (Girish et al., Chest 2001) y ShuttleTest (Singh et al., Thorax 1992) con medición de escala de Borg de miembros inferiores y disnea, saturación arterial y frecuencia cardíaca. A través de una máscara nasal, se adaptó VNI con promedio 15 cmH2O de IPAP y 4 cmH2O de EPAP, y luego se realizaronlas mismas pruebas de ejercicio. Fueron evaluados 11 pacientes con EPOC: mediana edad: 61 años (IC25-75%, 58-75), sexo masculino 72%, FVC: 65% (IC25-75%, 60,1-70); FEV1: 37,4(IC25-75%, 33,97-42,5); FEV1/FVC: 46 (IC25-75%, 42,5-52,5); PaO2:68 mmHg (IC25-75%,63-75,3); PaCO2:40mmHg (IC25-75%,39-41).En la prueba de 6 minutos, se observó que la VNI aumentaba la distancia caminada en 61.78 % (p=0.001) la distancia caminada y la carga (kg.m) en 16,55% (p=0.002). No había cambios significativos en los síntomas (fatiga y disnea) por escala de Borg. En la prueba de escalera, se observó que la VNI incrementaba la velocidad de ascensoen 11,81% (p=0.05), sin cambios significativos en los síntomas o la altura ascendida. En el shuttle test, se observó que la VNI aumenta la distancia caminada en 30.6% (p=0.001), sin cambio significativos en los síntomas.En conclusión, se observó una significativa mejoría en las distancias caminadas y mayor velocidad de ascenso en la de escalera. Es la primera comunicación del efecto de la VNIsobre pruebas de escalera en pacientes con EPOC.
There are few exercise studies about the effect of bi-level non-invasive ventilation (NIV) on the exercise in COPD patients. The objective of the study was to evaluate the impact of NIV on the results of submaximal and maximal field exercise tests in COPD patients. The COPD patients were selected according to the GOLD definition. The study tests included: the six minute walking test (ATS guidelines), stair climbing test (Girish et al., Chest 2001) and shuttle test (Singh et al., Thorax 1992) which were measured with the Borg scale for legs and dyspnea, arterial saturation and heart rate. With a nasal mask, the NIV was adapted with pressure support ventilation through 15 cm H2O of IPAP and 4 cm H2O of EPAP. Then, the same exercise tests were performed. Eleven COPD patients were evaluated: age (median) 61 years (IC25-75%, 58-75), male sex 72%, FVC: 65% (IC25-75%, 60.1-70); FEV1: 37.4(IC25-75%, 33.97-42.5); FEV1/FVC: 46 (IC25-75%, 42.5-52.5); PaO2: 68 mmHg (IC25-75%,63-75.3); PaCO2: 40mmHg(IC25-75%, 39-41). The NIV increased the walked distance by 61.78% (p=0.001) and load (kg.m) by 16.55%(p=0.002) in the six minute walking test. There was no significant difference in the symptoms (dyspnea and fatigue) in the Borg scale. The NIV increased the ascent velocity by 11.81% (p=0.05) in the stair climbing test. No significant changes in symptoms and ascended height were observed. The NIV increased the walked distance by 30.6% (p=0.001), without significant changes in symptoms. As conclusion, distance increased significantly with NIV in the six minute walking test and shuttle test. A higher velocity was observed in the stair climbing test. This study was the first experience of NIV on the stair climbing test in COPD patients.